Brivekimig Antibody
Brivekimig is a unique chimeric antibody composed of five variable heavy (VH) domains, designed to target TNFSF4, TNFSF2, and ALB. It serves as a research tool for investigating these targets in both in vitro binding assays and in vivo models of inflammation and oncology.
Product Specifications
Target
TNF
Conjugation
Unconjugated
Field of Research
Cell Biology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
